LEADER 03206oam 22005054a 450 001 9910154686703321 005 20230621141058.0 010 $a0-8135-8648-8 010 $a0-8135-8649-6 024 7 $a10.36019/9780813586496 035 $a(CKB)3710000000971791 035 $a(MiAaPQ)EBC4769486 035 $a(OCoLC)966429822 035 $a(MdBmJHUP)muse57789 035 $a(DE-B1597)526334 035 $a(DE-B1597)9780813586496 035 $a(ScCtBLL)51ada7ee-8b57-40bc-aa49-effc2488b433 035 $a(EXLCZ)993710000000971791 100 $a20160713d2017 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aClinical Trials in Ovarian Cancer$fChristine S. Walsh 210 1$aNew Brunswick, New Jersey :$cRutgers University Press,$d[2017] 210 4$dİ[2017] 215 $a1 online resource (336 pages) $cillustrations, tables 311 $a0-8135-8647-X 320 $aIncludes bibliographical references and index. 327 $aEarly stage epithelial ovarian cancer -- Advanced stage epithelial ovarian cancer : adjuvant chemotherapy -- Advanced stage epithelial ovarian cancer : timing of surgery and interval cytoreduction -- Epithelial ovarian cancer : maintenance therapy -- Recurrent epithelial ovarian cancer. 330 $aWhen a patient is diagnosed with a gynecological malignancy, she and her doctors must make urgent, high-risk decisions about her course of treatment. In selecting an appropriate plan of care, physicians must weigh the patient's individual needs, the tumor's specific characteristics, and the treatment's potential side effects. Because there is no one-size-fits-all treatment solution, a plethora of clinical trials have been performed on ovarian cancer patients, but clinicians may struggle to keep up with this ever-growing body of research. Collecting and synthesizing research findings from a wide array of medical journal articles and book chapters, Clinical Trials in Ovarian Cancer provides physicians with an invaluable resource. Gynecologic oncologist Christine S. Walsh systematically outlines each of the seminal Phase III trials that have shaped the treatment of ovarian cancers, detailing the rationale for the trial, the patient population studied, treatment delivery methods, efficacy, toxicity, and trial conclusions. She provides a clear overview of established treatments, as well as still-controversial experimental approaches. The first book to organize this cutting-edge research into an easy-to-use reference, Clinical Trials in Ovarian Cancer should help medical personnel at all levels provide their patients with the highest standard of care. 606 $aClinical Trials, Phase III as Topic 606 $aOvarian Neoplasms$xtherapy 608 $aElectronic books. 615 20$aClinical Trials, Phase III as Topic 615 10$aOvarian Neoplasms$xtherapy 676 $a616.99/465 700 $aWalsh$b Christine S.$f1972-$01024741 801 0$bMdBmJHUP 801 1$bMdBmJHUP 906 $aBOOK 912 $a9910154686703321 996 $aClinical Trials in Ovarian Cancer$92435751 997 $aUNINA